ESR1 and breast cancer: Furthermore, MRTF/SRF target genes' expression was positively associated with basal marker (CDH3), but negatively correlated with luminal marker (ESR1) (Figure 6C), suggesting that the activity of MRTF/SRF is higher in basal-like breast cancers than other subtypes.